申请人:Abbott Laboratories
公开号:US05142056A1
公开(公告)日:1992-08-25
A retroviral protease inhibiting compound of the formula A--X--B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is (1) substituted amino, (2) substituted carbonyl, (3) functionalized imino, (4) functionalized alkyl, (5) functionalized acyl, (6) functionalized heterocyclic or (7) functionalized (heterocyclic)alkyl; and B is (1) substituted carbonyl independently defined as herein, (2) substituted amino independently defined as herein, (3) functionalized imino independently defined as herein, (4) functionalized alkyl independently defined as herein, (5) functionalized acyl independently defined as herein, (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein.
一种抑制逆转录病毒蛋白酶的化合物,其化学式为A--X--B或其药用盐、前药或酯,其中X为连接基;A为(1)取代氨基,(2)取代羰基,(3)官能化亚胺基,(4)官能化烷基,(5)官能化酰基,(6)官能化杂环基或(7)官能化(杂环)烷基;B为(1)取代羰基,独立定义如本文所述,(2)取代氨基,独立定义如本文所述,(3)官能化亚胺基,独立定义如本文所述,(4)官能化烷基,独立定义如本文所述,(5)官能化酰基,独立定义如本文所述,(6)官能化杂环基,独立定义如本文所述或(7)官能化(杂环)烷基,独立定义如本文所述。